News Releases

CHRISTUS Ochsner St. Patrick Hospital welcomes urologist and urologic oncologist Olamide Omidele, MD

Dr. Omidele specializes in minimally invasive and robot-assisted care for prostate, kidney and bladder conditions. 

Ochsner ranked No.1 in Louisiana by U.S. News & World Report

For the 15th consecutive year, Ochsner Medical Center – New Orleans has been named the No. 1 hospital in Louisiana by U.S. News & World Report for 2026–2027, earning national rankings in obstetrics and gynecology and pulmonary care along with high performing honors across multiple specialties and procedures.

Ochsner MD Anderson earns national accreditation and recognition for excellence in cancer care

Together, these recognitions illustrate Ochsner MD Anderson’s focus on delivering coordinated comprehensive cancer care from prevention and screening to diagnosis, treatment and survivorship. Ochsner MD Anderson’s multidisciplinary approach brings together specialists across cancer disciplines to support patients with complex and varied needs.

Ochsner Health Research Week showcases biomedical discovery and clinical trial innovation

Ochsner hosts no-cost Iberville Parish health fair to promote cancer awareness and prevention

The Iberville Parish Health Fair & Community Celebration connected community members with local providers for health screenings, education and prevention resources.

Ochsner research team reports safe and effective outcomes with emerging combination therapy for liver cancer

As an early adopter of combination treatments, the research team was able to provide an early experience regarding the safety and efficacy of combination treatments in advance of clinical trial results. 

Ochsner MD Anderson to be first in the southern U.S. to offer precision cancer radiation treatment

The new treatment uses the unique biology of the cancer itself to guide radiotherapy delivery, even in tumors that are in motion.

Ochsner MD Anderson uses groundbreaking TIL therapy to treat advanced melanoma in adults

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to provide an adult patient with tumor-infiltrating lymphocytes (TIL) therapy for advanced melanoma.  

Breakthrough non-invasive liver tumor treatment now available at Ochsner MD Anderson

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes primary liver tumors originating in the liver, or metastasized tumors resulting from another cancer spreading to the liver. Histotripsy is a new option for patients with liver tumors who may not be a candidate for surgery or other traditional therapies. 

Ochsner research leads groundbreaking findings for Multi-Cancer Early Detection (MCED)

Entitled “Real-world data and clinical experience from over 100,000 multi-cancer early detection tests,” the study was recently published in Nature Communications.